This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H1N2 Neuraminidase (NA), N-His
Product Overview
BioVenic's Recombinant Influenza A H1N2 Neuraminidase (NA), N-His is a recombinant protein expressed from HEK293 Cells. Its predicted molecular weight is 50.6 kDa. The purity is>85% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL).
Specifications
Target Information
Influenza A virus subtype H1N2 (A/H1N2) belongs to the species Influenza A virus, sometimes referred to as bird flu or swine flu. This subtype is currently endemic in pig populations and occasionally infects humans. Neuraminidase of influenza A and B viruses plays a critical role in the virus life cycle and is an important target of the host immune system.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
References
- Creytens, Sarah et al. "Influenza Neuraminidase Characteristics and Potential as a Vaccine Target." Frontiers in immunology vol. 12 786617.